News

Partnership focused on improving public access to AEDs and CPR & AED training programs Physio-Control, a leading provider of emergency medical response technologies worldwide, and the American Red Cross, the nation’s leading provider of...

BioVentrix, a pioneer of technologies and procedures for the less-invasive treatment of heart failure (HF), announced the successful first-use of its Revivent™ Myocardial Anchoring System, via Less Invasive Ventricular Enhancement™ or the...

T32 grant funding trains next generation of leaders in clinical and outcomes research Saint Luke's Mid America Heart Institute — one of the leading outcomes research centers in the nation — is seeking highly motivated, talented individuals...

New Impella CP Reaches 1,000th Global Patient Milestone Abiomed, Inc., a leading provider of breakthrough heart support technologies, reported that physicians have implanted more than 15,000 Impella® pumps in U.S. patients requiring...

TYRX, Inc. announced today that the first implantation of its new AIGISRx R Fully Resorbable Antibacterial Envelope has taken place at the Vanderbilt Heart and Vascular Institute in Nashville, TN by Dr. Christopher R. Ellis. The AIGISRx R...

Company Seeks to Expand U.S. Labeling; Anticipates Accelerated Enrollment Under Recently Revised Protocol Hansen Medical, Inc., a global leader in intravascular robotics, announced that the first patients have been successfully enrolled in...

Simulator helps sponsors to assess arrhythmia risk before a candidate enters clinical trials; determine safe drug doses for specific patient populations Certara™, a leading provider of software and scientific consulting services to improve...

eCardio Diagnostics (www.ecardio.com), a leader in remote arrhythmia monitoring services, has promoted John H. Untereker to President, effective immediately. He will remain COO. Untereker will replace Larry Lawson, the company's founder, as...

Boston Scientific Corporation has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rhythmia™ Mapping System, a next-generation 3D mapping and navigation solution for use in cardiac catheter ablations and other...

ARCA biopharma, Inc. (Nasdaq:ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that it has expanded the Company’s clinical trial leadership team with three new hires in...